Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01820234 · ClinicalTrials.gov registry record · NA
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
A NA study of Skin Cancer and Telemedicine, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT01820234: Completed NA study of Skin Cancer and Telemedicine, sponsored by University of California, Davis.
NCT01820234 is a NA study of Skin Cancer and Telemedicine that has completed, run by University of California, Davis. The registered enrollment target is 170 participants, below the 460-participant average among 40 other Skin Cancer trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01820234, a NA study of Skin Cancer and Telemedicine, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event. The investigators' hypotheses include the following: 1. Compared to in-person assessment, store-and-forward teledermatology assessment will result in adequate diagnostic concordance. 2. Compared to in-person assessment, store-and-forward teledermatology results in adequate management concordance. 3. The sensitivity and specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant will be similar to that of in-person evaluation.
Primary Outcome
Aggregated diagnostic concordance which is defined as the agreement of the in-person dermatologist's principle diagnosis with the teledermatologist's primary diagnosis or any of the differential diagnoses.
Conditions Studied
Interventions
- OTHER In-person dermatology evaluation
- OTHER Store-and-forward teledermatology evaluation
Study Locations (1)
California
- University of California, Davis Shifa Community Clinic - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01820234 record still lists
NCT01820234 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 460-participant average among 40 other Skin Cancer trials with a reported enrollment target (63% lower).
The record links to 3 conditions, with Skin Cancer appearing as the primary indexed condition, and to 2 interventions - of which In-person dermatology evaluation is the first listed.
NCT01820234 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01820234 about?
NCT01820234 is a clinical study titled "Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event". The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event. The investigators' hypotheses include the following: 1. Compared to in-person assessment, store-and-forwa...
What is the current status of trial NCT01820234?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2010-09. Estimated completion is 2011-06.
What conditions does trial NCT01820234 study?
This clinical trial studies the following conditions: Skin Cancer, Telemedicine, Screening.
What interventions are being tested in trial NCT01820234?
The interventions under investigation include: In-person dermatology evaluation (OTHER), Store-and-forward teledermatology evaluation (OTHER).
Who is sponsoring clinical trial NCT01820234?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01820234 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01820234's enrollment target sits among peer trials
170 14th of 40 higher than 27 of 40 other Skin Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rural Adult and Youth Sun Protection Study
RECRUITING · NA
-
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
RECRUITING · NA
-
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
RECRUITING · NA
-
DNA Repair Activity in the Skin of Day and Night Shift Workers
RECRUITING · NA
-
Adaptive Symptom Self-Management Immunotherapy Study
RECRUITING · NA
-
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia